Clinical trials
Completed Phase 1 Breast Carcinoma In Situ trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 3 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Mayo Clinic | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| Katherine D. Crew | 1 |
| NYU Langone Health | 1 |
| Roswell Park Cancer Institute | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
| University of Kansas Medical Center | 1 |
| University of Medicine and Dentistry of New Jersey | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Carcinoma In Situ | 14 |
| Breast Neoplasms | 9 |
| Carcinoma, Intraductal, Noninfiltrating | 8 |
| Carcinoma, Ductal, Breast | 1 |
| Triple Negative Breast Neoplasms | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.